Ophthalmology

Agomelatine cuts ocular pressure with glaucoma

(HealthDay)—Oral systemic agomelatine has a hypotensive effect that decreases intraocular pressure (IOP) in both eyes of treatment-resistant primary open angle glaucoma (POAG) patients, according to a study published in ...

Other

Valeant pitches potential eye drug, research focus

Valeant Pharmaceuticals is drawing attention to a potential glaucoma treatment and its focus on product development, as the Canadian drugmaker continues to build its case to investors for a takeover of Botox-maker Allergan.

Ophthalmology

A second look at glaucoma surgery

New research led by Queen's University professor Robert Campbell (Ophthalmology) has revealed using anti-inflammatory medications after glaucoma laser surgery is not helpful or necessary.

Ophthalmology

Evaluating telephone calls to help glaucoma patients

(Medical Xpress) -- Interactive telephone calls and tailored print materials helped glaucoma patients adhere to their treatment better, but not significantly as compared with a control group. The report on a randomized controlled ...